Insmed insider Form 4 shows 5,000-share sale by director

Rhea-AI Filing Summary

Insmed Inc. (INSM) reported an insider transaction on a Form 4 filing. A company director sold 5,000 shares of Insmed common stock on November 24, 2025, identified with transaction code "S" for a sale. The shares were sold at a price of $204.58 per share in an open market transaction.

After this sale, the director beneficially owns 58,729 shares of Insmed common stock, held directly. The filing reflects a routine update to the director’s ownership position and does not report any derivative securities activity.

Insider Trade Summary

Net Seller: 5,000 shares ($1,022,900)

Net Sell 1 txn

Insider ANDERSON ELIZABETH M

Role Director

Sold 5,000 shs ($1.02M)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$204.58	$1.02M

Holdings After Transaction: Common Stock — 58,729 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANDERSON ELIZABETH M

(Last) (First) (Middle)

700 US HIGHWAY 202/206

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSMED Inc [ INSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/24/2025		S		5,000	D	$204.58	58,729	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Elizabeth M. Anderson, by Michael A. Smith as Attorney-in-fact	11/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Insmed (INSM) report on this Form 4?

The Form 4 reports that a director of Insmed Inc. (INSM) sold 5,000 shares of common stock in an open market transaction on November 24, 2025.

At what price were the Insmed (INSM) shares sold in the Form 4 filing?

The director sold 5,000 shares of Insmed common stock at a price of $204.58 per share.

How many Insmed (INSM) shares does the insider own after the reported sale?

Following the reported transaction, the director beneficially owns 58,729 shares of Insmed common stock, held directly.

What is the reporting person’s relationship to Insmed (INSM)?

The reporting person is identified as a Director of Insmed Inc. and filed the Form 4 as a single reporting person.

Does this Insmed (INSM) Form 4 include any derivative securities transactions?

No derivative securities transactions are reported. The table for derivative securities is present but shows no acquired or disposed derivative positions.

What transaction code is shown for the Insmed (INSM) insider trade?

The transaction is coded as "S", which denotes an open market or private sale of non-derivative securities.